TY - JOUR
T1 - Pseudotumour cerebri - Incidence, management and prevention
AU - Go, KG
PY - 2000/7
Y1 - 2000/7
N2 - Benign or idiopathic intracranial hypertension, also termed 'pseudotumour cerebri', is defined by the presence of raised intracranial pressure (ICP) in the absence of a focal intracerebral space-occupying lesion. The signs and symptoms of elevated intracranial pressure are also observed such as headaches, nausea and vomiting, elevated arterial pressure and, often, bradycardia. Somnolence and palsy of the abducens nel ve are occasionally observed, while papilloedema causing reduction of visual acuity and blindness is a particularly defining feature.
AB - Benign or idiopathic intracranial hypertension, also termed 'pseudotumour cerebri', is defined by the presence of raised intracranial pressure (ICP) in the absence of a focal intracerebral space-occupying lesion. The signs and symptoms of elevated intracranial pressure are also observed such as headaches, nausea and vomiting, elevated arterial pressure and, often, bradycardia. Somnolence and palsy of the abducens nel ve are occasionally observed, while papilloedema causing reduction of visual acuity and blindness is a particularly defining feature.
KW - BENIGN INTRACRANIAL HYPERTENSION
KW - TRANS-RETINOIC ACID
KW - ACUTE PROMYELOCYTIC LEUKEMIA
KW - SYSTEMIC LUPUS-ERYTHEMATOSUS
KW - INTRA-CRANICAL HYPERTENSION
KW - NERVE SHEATH DECOMPRESSION
KW - INFLAMMATORY BOWEL-DISEASE
KW - GROWTH-HORMONE DEFICIENCY
KW - L-THYROXINE THERAPY
KW - VITAMIN-A
M3 - Review article
SN - 1172-7047
VL - 14
SP - 33
EP - 49
JO - Cns Drugs
JF - Cns Drugs
IS - 1
ER -